Dr. Rainer Storb received an honorary award from the American Association for Cancer Research for research accomplishments in transplantation biology that have defined and improved treatment and increased long-term survival of cancer patients.
Storb, an investigator in the Clinical Research Division, will accept the award and deliver a lecture at the AACR annual meeting in New Orleans in March.
The Joseph H. Burchenal Clinical Research Award is awarded each year to a scientist who has made outstanding achievements in clinical cancer research and is named for a leader in the field of cancer chemotherapy.
Storb, who heads the Transplantation Biology Program and is a professor of medicine at the University of Washington, has been a leader in the development of bone-marrow transplantation as successful therapy for leukemia and other blood disorders.
His research focuses on developing novel transplant procedures that minimize the use of radiation and chemotherapy. Such so-called "mini-transplants" often can be performed without hospitalization.
